Mera Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2020	FY 2019	FY 2011	FY 2010	FY 2009
Period Ending	Jul '21 Jul 31, 2021	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019	Oct '11 Oct 31, 2011	Oct '10 Oct 31, 2010	Oct '09 Oct 31, 2009
Cash & Equivalents	-	-	-	0	0.01	0
Cash & Short-Term Investments	-	-	-	0	0.01	0
Cash Growth	-	-	-	-27.36%	89.47%	-94.16%
Accounts Receivable	-	-	-	0.01	0.01	0.01
Receivables	-	-	-	0.01	0.01	0.01
Prepaid Expenses	-	-	-	0.04	-	-
Other Current Assets	-	-	-	-	-	0.02
Total Current Assets	-	-	-	0.05	0.01	0.03
Property, Plant & Equipment	-	-	-	0	0.01	0.2
Other Long-Term Assets	-	-	-	0.01	0.05	0.03
Total Assets	-	-	-	0.07	0.07	0.26
Accounts Payable	0.04	0.03	0.02	0.49	0.37	0.16
Accrued Expenses	-	-	-	0.15	0.15	0.15
Short-Term Debt	-	-	-	0.3	0.23	0.05
Current Unearned Revenue	-	-	-	-	-	0.03
Total Current Liabilities	0.04	0.03	0.02	0.94	0.75	0.4
Total Liabilities	0.04	0.03	0.02	0.94	0.75	0.4
Common Stock	0.06	0.06	0.06	0.05	0.05	0.05
Additional Paid-In Capital	8.38	8.38	8.38	7.97	7.97	7.97
Retained Earnings	-8.47	-8.46	-8.46	-8.89	-8.7	-8.16
Treasury Stock	-0	-0	-0	-0	-0	-0
Total Common Equity	-0.04	-0.03	-0.02	-0.86	-0.68	-0.14
Shareholders' Equity	-0.04	-0.03	-0.02	-0.86	-0.68	-0.14
Total Liabilities & Equity	-	-	-	0.07	0.07	0.26
Total Debt	-	-	-	0.3	0.23	0.05
Net Cash (Debt)	-	-	-	-0.29	-0.22	-0.05
Net Cash Per Share	-	-	-	-0.00	-0.00	-0.00
Filing Date Shares Outstanding	556.8	556.8	557.3	556.8	547.27	547.27
Total Common Shares Outstanding	556.8	556.8	557.3	547.27	547.27	547.27
Working Capital	-0.04	-0.03	-0.02	-0.88	-0.74	-0.37
Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Tangible Book Value	-0.04	-0.03	-0.02	-0.86	-0.68	-0.14
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Machinery	-	-	-	0.11	0.11	0.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.